10 YEARS EXPERIENCE OF TYROSINE KINASE INHIBITOR THERAPY FOR CML IN A SINGLE UK CENTRE: COMPARISON WITH PRE-TKI ERA AND EVALUATION OF 2013 ELN GUIDELINES
Khan D., Roy N., Bari V., Vallance G., Dreau H., Littlewood T., Peniket A., Vyas P., Foroni L., Schuh A., Mead A.